Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis

Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis

Abstract Background Promising efficacy and manageable toxicity of docetaxel-based concurrent chemoradiotherapy (CCRT) were reported in head and neck cancer. In addition, the effect of CCRT in combination with cisplatin and/or 5-fluorouracil on both locoregionally advanced and metastatic/recurrent na...

Full description

Bibliographic Details
Main Authors: Jun-Fang Liao, Qun Zhang, Xiao-Jing Du, Mei Lan, Shan Liu, Yun-Fei Xia, Xiu-Yu Cai, Wei Luo
Format: Article
Language:English
Published: Wiley 2019-06-01
Series:Cancer Communications
Subjects:
Concurrent chemoradiotherapy
Docetaxel
Cisplatin
Nasopharyngeal carcinoma
Propensity score matching
Intensity-modulated radiotherapy
Online Access:http://link.springer.com/article/10.1186/s40880-019-0380-x

Internet

http://link.springer.com/article/10.1186/s40880-019-0380-x

Similar Items